Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study-Reference-Cited by-同舟云学术

Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study

Published:2021-10 Issue:10 Volume:21 Page:1441-1447
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Bettuzzi Thomas,Jourdes Aurélie,Robineau Olivier,Alcaraz Isabelle,Manda Victoria,Molina Jean Michel,Mehlen Maxime,Cazanave Charles,Tattevin Pierre,Mensi Sami,Terrier Benjamin,Régent Alexis,Ghosn Jade,Charlier Caroline,Martin-Blondel Guillaume,Dupin Nicolas

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. Neurosyphilis;Ropper;N Engl J Med,2019

2. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection;Gordon;N Engl J Med,1994

3. The modern epidemic of syphilis;Ghanem;N Engl J Med,2020

4. 2014 European guideline on the management of syphilis;Janier;J Eur Acad Dermatol Venereol,2014

5. Sexually transmitted diseases treatment guidelines, 2015;Workowski;MMWR Recomm Rep,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression, anxiety, lower sleep quality and social support in square cabin hospitals during Shanghai’s COVID-19 lockdown, China;Frontiers in Psychiatry;2024-02-05

2. Infectious and Postinfectious Vasculopathies;Neuroimaging Clinics of North America;2024-02

3. Neurosyphilis: insights into its pathogenesis, susceptibility, diagnosis, treatment, and prevention;Frontiers in Neurology;2024-01-11

4. Overview of management of infection-related movement disorders with focus on specific-infections;Clinical Parkinsonism & Related Disorders;2024-01

5. Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial;The Lancet Infectious Diseases;2024-01